Juva Life Launches Revised JuLi Registry, Showcases Cannabis and CBD Brands to Track Effects on Cannabis Patients
Juva Life Launches Revised JuLi Registry, Showcases Cannabis and CBD Brands to Track Effects on Cannabis Patients
Life Science Research and Vertically Integrated California Cultivator Creates Global Research Registry to Better Understand Clinical Effects of Cannabis
生命科學研究公司和垂直整合的加州種植者公司創建全球研究註冊中心，以更好地瞭解大麻的臨牀效果
VANCOUVER, British Columbia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) ("Juva Life," "Juva" or the "Company"), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, today announced their newly revised WCG IRB-approved cannabis patient registry, renamed to the JuLi Registry ("The Registry").
温哥華，不列顛哥倫比亞省，2022年8月16日(Global Newswire)--Juva Life Inc.(CSE：JUVA)(OTCQB：JUVAF)(法蘭克福：4VV)(“Juva Life”，“Juva”或“公司”)，一家在大麻生產和分銷領域擁有藥物研發和麪向消費者業務的生命科學公司，今天宣佈其新修訂的經WCG IRB批准的大麻患者登記，更名為Juli註冊中心(以下簡稱“註冊中心”)。
The JuLi Registry is a WCG IRB -approved multi-year study conducted through Juva Life's cannabis research division. The Registry, listed on clinicaltrials.gov, is aimed at amassing one of the world's largest data sets of real-world clinical evidence on the potential health benefits of cannabis. It enjoys participation from best-in-class cannabis and cannabidiol (CBD) brands, and includes products from CannaCraft, dosist, LEVEL, San Benito Hemp Company, Sunderstorm, and WYLD.
Juli註冊是WCG IRB批准的一項多年研究，通過Juva Life的大麻研究部門進行。該註冊表在Clinicaltrials.gov上列出，旨在收集世界上最大的真實世界臨牀證據數據集之一，説明大麻對健康的潛在好處。它得到了同類最好的大麻和大麻二醇(CBD)品牌的參與，包括CannaCraft、DOSIST、Level、San Benito hemp Company、SunderStorm和Wyld的產品。
Once completed, Juva will have one of the largest data sets of its kind and will be able to leverage the findings in both its nutraceutical wellness, drug development and clinical programs. This real-world observational data, overseen by physicians and other clinicians, will be presented to various regulatory bodies to show the potential therapeutic benefits of cannabis and hemp-derived compounds.
一旦完成，Juva將擁有同類數據中最大的數據集之一，並將能夠利用其營養食品健康、藥物開發和臨牀項目中的發現。這些由醫生和其他臨牀醫生監督的真實世界觀察數據將提交給各種監管機構，以顯示大麻和大麻衍生化合物的潛在治療益處。
"The Juli Registry will amass one of the largest repositories of real-world data of its kind, tracking the medicinal effects of cannabis use, which few companies globally are seeking to create," said Doug Chloupek, CEO and Founder of Juva. "Thanks to the participation of our world-class brands, cannabis patients nationwide can track the effectiveness of a broad selection of curated products which may help individual participants and researchers better understand clinical benefits from specific products and dosing schedules. The data we collect is kept confidential, and this study is crucial in understanding the medicinal benefits of cannabis-based products through real-world data gathering."
Juva首席執行官兼創始人道格·克洛佩克表示：“Juli註冊處將積累同類最大的現實世界數據倉庫之一，追蹤大麻使用的醫療效果，而全球很少有公司尋求創建這一數據庫。”多虧了我們世界級品牌的參與，全國的大麻患者可以跟蹤廣泛選擇的經過管理的產品的有效性，這可能有助於個人參與者和研究人員更好地瞭解特定產品和劑量計劃的臨牀益處。我們收集的數據是保密的，這項研究對於通過真實世界的數據收集了解以大麻為基礎的產品的藥用益處至關重要。
"The cannabis plant has such remarkable therapeutic promise. Yet research has been stymied for decades by federal restrictions," says Tiffany Devitt, Chief of Regulatory Affairs for CannaCraft. "We're thrilled that Juva is taking the initiative to creatively work around restrictions and essentially crowd-sourcing data from the millions of people using this long-standing herbal remedy."
CannaCraft的監管事務負責人蒂凡尼·德維特説：“大麻植物具有如此顯著的治療前景。然而，幾十年來，研究一直受到聯邦限制的阻礙。”“我們很高興，Juva主動繞過了限制，從本質上説是從數百萬使用這種長期草藥的人那裏眾包數據。”
"Since inception, dosist has been a pioneer in the study of cannabinoids and their positive clinical effect for consumers," stated Jason DeLand, Executive Chairman and Co-Founder of dosist. "Precise dosage, exact formulations and maximum bioavailability are paramount to creating a consistent, repeatable experience that engenders consumer trust, and we applaud Juva's efforts to further confirm and elevate the targeted usage and wellness benefits of this amazing plant."
"Cannabinoids have a myriad of therapeutic properties, and we're just starting to define their positive impact on human health," said LEVEL Founder and CEO Chris Emerson, PhD. "At LEVEL, we're dedicated to conducting research, pushing the scientific boundaries, and driving consumer education about cannabinoids, which facilitates our unique approach to developing innovative cannabis products. Leveraging real-world clinical evidence on the potential health benefits of cannabis will shape the future of the industry, and LEVEL is excited to participate in this important work."
DOASIST執行主席兼聯合創始人賈森·德蘭德説：“自成立以來，DOASTE一直是研究大麻類藥物及其對消費者的積極臨牀效果的先驅。精確的劑量、精確的配方和最大的生物利用度對於創造一致的、可重複的體驗並贏得消費者的信任至關重要，我們讚揚Juva進一步確認和提升這種令人驚歎的植物的目標用途和健康益處的努力。“
Level創始人兼首席執行官克里斯·愛默生博士説：“大麻類藥物有無數的治療特性，我們剛剛開始定義它們對人類健康的積極影響。”在Level，我們致力於進行研究，突破科學界限，推動關於大麻類物質的消費者教育，這有助於我們開發創新的大麻產品的獨特方法。利用關於大麻潛在健康益處的真實世界臨牀證據將塑造該行業的未來，Level很高興參與這項重要的工作。
"We find it our duty to help showcase what this amazing plant is really capable of," says Matthew Mielczarek, CEO and Co-Founder of San Benito Hemp Company. "The cannabis plant has so many uses, we have only begun to scratch the surface of its medicinal qualities. We are extremely excited to be working with Juva on this groundbreaking study that will not only enlighten all of our understandings of the cannabis plant but help guide us for future growth."
聖貝尼託大麻公司首席執行官兼聯合創始人Matthew Mielczarek説：“我們發現，幫助展示這種神奇的植物的真正能力是我們的責任。”“大麻植物的用途如此之多，我們才剛剛開始觸及其藥用價值的皮毛。我們非常高興能與Juva合作進行這項開創性的研究，這不僅將啟發我們對大麻植物的所有理解，還有助於指導我們未來的成長。”
"At Sunderstorm, wellness has been the foundation of everything we do, leading to the development of our Tranquility gummy which was scientifically designed to assist in sleep-related issues," said Cameron Clark, CEO and Co-Founder of Sunderstorm. "We are proud to support Juva's efforts to further validate the health benefits and efficacy of our Tranquility product and cannabis products within the industry at large."
桑德風暴公司首席執行官兼聯合創始人卡梅隆·克拉克説：“在桑德風暴，健康一直是我們所做一切的基礎，這導致了我們的寧靜口香糖的開發，這種膠經過科學設計，可以幫助解決與睡眠相關的問題。”我們很自豪地支持Juva進一步驗證我們的寧靜產品和整個行業內大麻產品的健康益處和功效的努力。“
The goal of the Registry is to collect data on cannabis formulations, chemical composition, dosing and utilization, and the effectiveness of cannabis products in addressing designated medical concerns. The study is open to patients over 21 years of age who have the following conditions or symptoms: chronic pain, anxiety, neuropathy, appetite issues, nausea, sleep issues, and menopausal symptoms. Info on products selected, dosing schedules, impact on symptoms and side effects will be collected. Additionally, the Registry will examine patients' use of cannabis in conjunction with other prescription medication, including any discontinuation or reduction of the use of opioids after initiation of cannabis-based medications. Learn more and sign up for the JuLi Registry here:
登記處的目標是收集關於大麻配方、化學成分、劑量和用途以及大麻產品在解決特定醫療問題方面的有效性的數據。這項研究向21歲以上有以下情況或症狀的患者開放：慢性疼痛、焦慮、神經病變、食慾問題、噁心、睡眠問題和更年期症狀。將收集有關所選產品、給藥時間表、對症狀的影響和副作用的信息。此外，登記處將結合其他處方藥物檢查患者使用大麻的情況，包括在開始使用以大麻為基礎的藥物後是否停止或減少使用阿片類藥物。瞭解更多信息並在此處註冊Juli註冊表：
About CannaCraft
CannaCraft is a vertically-integrated company, founded in 2014 with the mission to produce safe and effective cannabis products. The company currently manufactures and distributes AbsoluteXtracts, Care By Design, Lagunitas Hi-Fi Sessions, Farmer & The Felon, and Loud+Clear from their licensed facilities in Santa Rosa, California. CannaCraft's product portfolio boasts hundreds of unique products, including vape cartridges, tinctures, topicals, soft gels, packaged flower, gummies, concentrates, and beverages. Learn more at .
關於CannaCraft
CannaCraft是一家垂直整合的公司，成立於2014年，其使命是生產安全有效的大麻產品。該公司目前在加利福尼亞州聖羅莎的特許設施中製造和分銷AbsolteXtracts、Care by Design、Lagunitas Hi-Fi Sessions、Farmer&The Fealon和Loud+Clear。CannaCraft的產品組合擁有數百種獨特的產品，包括Vape墨盒、酊劑、外用藥片、軟凝膠、包裝鮮花、口香糖、濃縮液和飲料。瞭解更多信息，請訪問。
About dosist
dosistTM, based in Los Angeles, California, launched in 2016 and has since become known as a disruptor in both the cannabis and health & wellness industries. dosist was named one of Time Magazine's Best Inventions, recognized by Fast Company as one of the Top 10 Most Innovative Companies in the health sector, and designated by LinkedIn as the number two Top Startups: Hottest U.S. Companies To Work For Now. dosist provides elevated consumer benefits and cannabinoid experiences through their regulated THC business featuring the best cannabis delivery systems and formulas in the vaporization and ingestible markets, and through their dosist health business, launched in late November 2020, expanding the company's reach across the wellness sector with a new range of CBD+ formulas and products available through its direct-to-consumer platform and at key retailers nationwide. For more information about dosist visit dosist.com and dosisthealth.com.
關於鴿派
DosistTM總部位於加利福尼亞州洛杉磯，於2016年推出，自那以來一直被認為是大麻行業和健康與健康行業的顛覆者。DOASTE被《時代》雜誌評為最佳發明之一，被Fast Company評為醫療行業最具創新性的十大公司之一，並被LinkedIn評為第二大創業公司：目前最熱門的美國公司。DOASTE通過其受監管的THC業務提供更高的消費者利益和大麻類體驗，該業務在蒸發和可食用市場擁有最佳的大麻輸送系統和配方，並通過其直接面向消費者的平臺和全國主要零售商推出的DOASTE健康業務，通過新的CBD+配方和產品系列擴大公司在健康領域的覆蓋範圍。有關DOASTE的更多信息，請訪問dosist.com和dosisthealth.com。
About LEVEL
LEVEL is a science-driven cannabis company at the forefront of cannabinoid research and innovation that is passionate about helping to guide humans with the information and products they need to make informed decisions and take action. We launched LEVEL with one goal in mind: to create unique, targeted, effects-based cannabis products by formulating cannabinoids in ratios inaccessible from the plant alone.
關於標高
Level是一家科學驅動的大麻公司，處於大麻類研究和創新的前沿，熱衷於幫助指導人類提供他們做出明智決定和採取行動所需的信息和產品。我們推出Level只有一個目標：通過以植物本身無法獲得的比例配製大麻類化合物，創造獨特的、有針對性的、基於效果的大麻產品。
About Sunderstorm
Established in California in 2015, Sunderstorm is one of the largest and most trusted manufacturers of cannabis products, currently serving the California, Nevada, Massachusetts, Colorado and Canadian markets. Their mission is to help people achieve a life of harmony and wellness with all-natural, consciously made, science-based cannabis products. Widely considered the best tasting gummy in the industry and the 4th-largest edible brand in the U.S., Sunderstorm's award-winning Kanha premium gummies are made with the highest-quality cannabis oils, scientifically extracted and infused to provide a consistent dose.
關於雷雨
桑德風暴於2015年在加利福尼亞州成立，是最大和最受信任的大麻產品製造商之一，目前服務於加利福尼亞州、內華達州、馬薩諸塞州、科羅拉多州和加拿大市場。他們的使命是幫助人們通過全天然的、有意識地製造的、基於科學的大麻產品來實現和諧和健康的生活。被廣泛認為是業內最佳口感的口香糖和美國第四大食用品牌，SunderStorm獲獎的Kanha優質口香糖使用最高質量的大麻油製成，經過科學提取和注入，以提供一致的劑量。
About San Benito Hemp Company
關於聖貝尼託大麻公司
Since launching in 2019, San Benito Hemp Company has pioneered a unique true solventless process using cutting edge technology to produce efficacious hemp products for a growing global market. Our mission is to promote wellness by offering the best and most dependable supply of Absolute-grade CBD extracts on the market. Our Absolute extraction process is optimized to capture the broadest spectrum of hemp compounds resulting in therapeutically-rich, high-grade products that embody the principles of wellness, balance and sustainability.
自2019年推出以來，聖貝尼託大麻公司開創了一種獨特的真正的無溶劑工藝，使用尖端技術為不斷增長的全球市場生產高效的大麻產品。我們的使命是通過提供市場上最好和最可靠的絕對級CBD精華來促進健康。我們的絕對提取工藝經過優化，以捕獲最廣泛的大麻化合物譜，從而產生體現健康、平衡和可持續原則的富含治療作用的高品位產品。
To learn more about the JuLi Registry, please visit:
要了解更多有關Juli註冊處的信息，請訪問：
ON BEHALF OF THE BOARD,
我代表董事會，
-Doug Chloupek-
-道格·克洛佩克-
Doug Chloupek, CEO and Founder
道格·克洛佩克，首席執行官兼創始人
Juva Life Inc.
JUVA Life Inc.
inquiries@juvalife.com
郵箱：queries@juvalife.com
About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRA: 4VV)
Juva Life Inc.(CSE：JUVA)(場外交易市場代碼：JUVAF)(FRA：4VV)簡介
Juva Life is employing state-of-the-art pharmaceutical research and development to discover, develop and commercialize safe and effective cannabis products. The Company is leveraging multi-disciplinary research experts across various fields standardization of cultivation, extraction, and formulation to offer consumers reproducible medical benefits. Juva is building upon these natural product process chemistry skills, to now include discovery pharmacology through a validated discovery technology platform. The Company will leverage revenue derived from its retail operations to advance JUVA-019, JUVA-041, and other potentially valuable non-cannabinoid bioactives for consumer and pharma product applications. Juva is working to bring the cannabis market face to face with the sector's next generation investment grade business model. Find out more at:
JUVA Life正在利用最先進的藥物研究和開發來發現、開發和商業化安全有效的大麻產品。該公司正在利用各個領域的多學科研究專家對種植、提取和配方進行標準化，為消費者提供可重複使用的醫療福利。JUVA正在這些天然產品過程化學技能的基礎上發展，現在通過一個經過驗證的發現技術平臺包括髮現藥理學。該公司將利用其零售業務的收入，推動JUVA-019、JUVA-041和其他潛在有價值的非大麻生物活性物質用於消費和製藥產品應用。JUVA正在努力使大麻市場與該行業的下一代投資級商業模式面對面。有關更多信息，請訪問：
For further information, please contact:
如需更多信息，請聯繫：
Juva Life Investor Relations
JUVA Life投資者關係
Tel: +1 833-333-5882 (JUVA)
電話： +1 833-333-5882 (JUVA)
Email: inquiries@juvalife.com
電子郵件：queries@juvalife.com
Investor Relations:
Kyle Porter
858.221.8001
juva@cmwmedia.com
投資者關係：
凱爾·波特
858.221.8001
郵箱：juva@cmwmedia.com
Corporate Contact:
1.833.333.JUVA (5882)
公司聯繫人：
1.833.333.JUVA(5882)
Forward Looking Statement
前瞻性陳述
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; product development, commercialization strategy and future collaborations.
本新聞稿包含的陳述和信息在某種程度上不是歷史事實，可能構成適用證券法意義上的“前瞻性信息”。前瞻性信息可能包括財務和其他預測，以及關於未來計劃、目標或經濟表現的陳述，或支持上述任何一項的假設。在一些情況下，前瞻性陳述可以用諸如“可能”、“將”、“可能”、“將”、“可能”、“例外”、“預期”、“相信”、“打算”、“計劃”、“預測”、“項目”、“估計”、“展望”或其否定或關於非歷史事實事項的其他類似表述來識別。此類陳述的例子包括但不限於關於公司目標和業務計劃、產品開發、商業化戰略和未來合作的陳述。
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company's management discussion and analysis for year ended December 31, 2020 under the heading "Risks and Uncertainties". Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all of such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
前瞻性信息涉及已知和未知的風險、不確定性和其他因素，可能導致公司的實際結果、業績或成就與前瞻性信息明示或暗示的任何未來結果、業績或成就大不相同，包括但不限於與公司未來業務計劃有關的風險、公司無法留住關鍵人員的風險、公司無法以合理條款或根本無法獲得融資的風險，以及公司在截至2020年12月31日的年度的管理層討論和分析中以“風險和不確定因素”的標題所描述的所有其他風險。因此，讀者不應過分依賴任何此類前瞻性信息。此外，任何前瞻性信息僅説明該聲明發表之日。新的因素不時出現，公司管理層無法預測所有這些因素並預先評估每個因素對公司業務的影響，或任何因素或因素組合可能導致實際結果與任何前瞻性信息中包含的結果大不相同的程度。除法律(包括證券法)要求外，本公司不承擔任何義務更新任何前瞻性信息，以反映發佈日期後的信息或事件，或反映意外事件的發生。
The CSE does not accept responsibility for the adequacy or accuracy of this release.
CSE不對本新聞稿的充分性或準確性承擔責任。
譯文內容由第三人軟體翻譯。